{"id":2237,"date":"2010-11-23T10:31:00","date_gmt":"2010-11-23T10:31:00","guid":{"rendered":"https:\/\/www2.thestockmarketwatch.com\/stock-market-news\/medtronic-acquiring-ardian\/2237\/"},"modified":"2010-11-23T10:31:00","modified_gmt":"2010-11-23T10:31:00","slug":"medtronic-acquiring-ardian","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/medtronic-acquiring-ardian\/2237\/","title":{"rendered":"Medtronic Acquiring Ardian"},"content":{"rendered":"<p><a rel=\"attachment wp-att-1682\" href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/recent-events\/bristol-myers-and-eli-lily-wins-major-ruling\/1912\/attachment\/health5\"><img decoding=\"async\" class=\"alignleft size-full wp-image-1682\" src=\"https:\/\/storage.googleapis.com\/smw-news-wp\/stock-market-news\/wp-content\/uploads\/2010\/11\/health5.jpg\"><\/a><strong>Medtronic<\/strong> (<a href=\"https:\/\/stockmarketwatch.com\/markets\/nyse\/today.aspx\" data-internallinksmanager029f6b8e52c=\"2\" title=\"NYSE Today\">NYSE<\/a>:<a href=\"https:\/\/thestockmarketwatch.com\/stock.aspx?stock=MDT\"><strong>MDT<\/strong><\/a>) the medical device maker is proposing a $800 million deal to acquire Ardian. <span id=\"more-2237\"><\/span>Ardian is a medical device maker with the latest high blood pressure catheter therapy. The deal is all cash payout. The Vice President of Medtronic, Sean Salmon stated that the deal also involves using Ardian\u2019s technology to increase the annual revenue till the end of 2015.<br \/>\nMedtronic (NYSE:MDT) currently owns more than 11% stake in Ardian. The newest catheter blood pressure therapy received appreciation at the recent American Heart Association scientific meeting. It has managed to reduce blood pressure on an average by up to 33 points in high BP patients after 6 months.<\/p>\n<div style=\"overflow: hidden;width: 1px;height: 1px\">\n<pre>Medtronic (NYSE:MDT) the medical device maker is proposing a $800 million deal to acquire Ardian. Ardian is a medical device maker with the latest high blood pressure catheter therapy. The deal is all cash payout. The Vice President of Medtronic, Sean Salmon stated that the deal also involves using Ardian\u2019s technology to increase the annual revenue till the end of 2015.\nMedtronic (NYSE:MDT) currently owns more than 11% stake in Ardian. The newest catheter blood pressure therapy received appreciation at the recent American Heart Association scientific meeting. It has managed to reduce blood pressure on an average by up to 33 points in high BP patients after 6 months.\n<\/pre>\n<\/div>\n<p>Related posts:<\/p>\n<ol>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/recent-events\/bird-flu-resurfaces\/2060\" rel=\"bookmark\" title=\"Permanent Link: Bird Flu Resurfaces\">Bird Flu Resurfaces<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/recent-events\/pfizer%e2%80%99s-help-with-heart-disease\/2000\" rel=\"bookmark\" title=\"Permanent Link: Pfizer\u2019s Help With Heart Disease\">Pfizer\u2019s Help With Heart Disease<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/recent-events\/lowering-cholesterol-getting-easier\/1998\" rel=\"bookmark\" title=\"Permanent Link: Lowering Cholesterol Getting Easier\">Lowering Cholesterol Getting Easier<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/recent-events\/japanese-firm-buying-genzyme\/1882\" rel=\"bookmark\" title=\"Permanent Link: Japanese Firm buying Genzyme\">Japanese Firm buying Genzyme<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/recent-events\/jane-fonda-confirms-breast-cancer\/1779\" rel=\"bookmark\" title=\"Permanent Link: Jane Fonda Confirms breast Cancer\">Jane Fonda Confirms breast Cancer<\/a><\/li>\n<\/ol>\n<div style=\"margin:5px;margin-bottom:20px;font-size:11pt;\">&laquo; <a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/\">Return to Stock Market News<\/a> &laquo; <\/div>\n<div style=\"padding:0px;margin:0px;margin-bottom:15px;\">\n<div style=\"width:338px;height:280px;\">\n<p><script type=\"text\/javascript\"><!--\ngoogle_ad_client = \"ca-pub-1408583772585547\";\n\/* SMW Single Post - Footer *\/\ngoogle_ad_slot = \"9968072899\";\ngoogle_ad_width = 336;\ngoogle_ad_height = 280;\n\/\/-->\n<\/script><br \/>\n<script type=\"text\/javascript\" src=\"http:\/\/pagead2.googlesyndication.com\/pagead\/show_ads.js\">\n<\/script><\/p>\n<\/div>\n<p><br style=\"clear:both\">\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medtronic (NYSE:MDT) the medical device maker is proposing a $800 million deal to acquire Ardian. Ardian is a medical device [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50312,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[1064,1066],"tags":[1456],"class_list":["post-2237","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recent-events","category-health","tag-mdt"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/2237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=2237"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/2237\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50312"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=2237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=2237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=2237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}